PVD Group Newsletter
Welcome to the winter edition of the Peripheral Vascular Diseases
New protocols published:
review group newsletter. In addition to the Editorial base update you will
Percutaneous transluminal arterial angioplasty versus
find details of our recently published reviews and protocols; information
stenting for infrapopliteal arterial lesions in critical limb
on Cochrane training opportunities, upcoming events including the
Venous Forum and details of our most accessed and cited reviews in
Lumber sympathectomy versus prostanoids for critical limb
ischaemia due to non-reconstructable peripheral arterial
We would like to introduce Cathryn Broderick who joined our team
in August. We also welcome Fay Crawford, Francesca Chappell and
Alina Andras who are busy implementing review writing in three of our
Subintimal angioplasty for chronic lower limb arterial
key areas: aortic abdominal aneurysm, venous thromboembolism and
peripheral arterial disease. This is possible thanks to recent funding
from NIHR, awarded jointly with Newcastle-upon-Tyne Hospitals NHS
The publishers of The Cochrane Library, Wiley-
Blackwell, have announced that the 2010 Impact Factor
New reviews published by the PVD Group in The Cochrane
of the Cochrane Database of Systematic Reviews is 6.186 -
ranking the CDSR in the top 10 of the ISI category
Medicine, General & Internal.
Endovenous ablation (radiofrequency and laser) and foam sclerotherapy
versus conventional surgery for great saphenous vein varices
Angioplasty versus stenting for subclavian artery stenosis
full text access of our reviews up by 7% since 2009. We
would like to take this opportunity to thank all the authors
Compression stockings for the initial treatment of varicose veins in
and referees who made this possible and to emphasise the
importance of citing our reviews where appropriate in order
to ensure our impact is maintained and improved.
Antiplatelet agents for intermittent claudication
Local intramuscular transplantation of autologous mononuclear cells for
The most accessed PVD group review for 2010 was
Elastic compression stockings for prevention of deep vein thrombosis by Sachdeva, Dalton, Amaragiri and
Remote ischaemic preconditioning versus no remote ischaemic
preconditioning for vascular and endovascular surgical procedures
Sclerotherapy for lower limb telangiectasias
The most cited review during both 2009 and 2010 was
Cilostazol for peripheral arterial disease by Robless,
Statins for primary prevention of venous thromboembolism
Mikhailidis and Stansby - congratulations to the authors!
Are there any topics within the scope of the PVD group that
PVD Editorial Base http://pvd.cochrane.org
you would like to see covered by a Cochrane systemic
Managing Editor - Marlene
review? If so we would love to know. Please contact the
Can you help? Consumer opinions are critical to our Cochrane reviews.We are looking for consumer referees to help
us with reviewing protocols and reviews from a non-clinical perspective. Consumers can be patients, carers or people with an
interest in peripheral vascular diseases. If you or someone you know would like to provide feedback on a review, please contact
the editorial base for more information. The Editorial base sends a huge thanks to all those who have acted as Consumer
Referees in th e past. Your input is greatly appreciated.
Stats pointer - choosing between fixed versus random
17th Annual Meeting of UK and Ireland-based
effects when performing a meta-analysis? Moving from a
Contributors to The Cochrane Collaboration
fixed to a random effects model if the test for
heterogeneity is significant (i.e. a data driven decision) is
strongly discouraged. When considering which type of
analysis to use here is a paper that discusses the models
Venous Forum Annual Spring Meeting
in bit more detail than the section on the handbook: Conference Theme: Venous Thromboembolism
Michael Borenstein et al. A basic introduction to fixed-
The Royal Society of Medicine, London, UK
effect and random-effects models for meta-analysis.
A two day conference promoting a multidisciplinary approach
Research Synthesis Methods 2010;1:97-111.
to the management of venous disease. Highlights include:
In this paper the authors explain the key assumptions of
Epidemiology of VTE, risk factors and sequelae; management
each model and outline the differences between the
and treatment of VTE; thrombosis mechanisms; new drugs;
models. They conclude with a discussion of factors to
cancer and VTE; pregnancy and VTE; venous thrombosis in
consider when choosing between the two models.
the paediatric patient. Email venous@rsm.ac.uk to register
The latest version of Rev Man – version 5.1 - was
updated earlier in the year. Please ensure you are
Workshops and online training are available to all
working from this version. You will be prompted to install
Cochrane review authors. Details can be found at
http://training.cochrane.org/. Please contact our editorial base
if you require an ARCHIE user account. If you are new to
writing a Cochrane review consider attending one or more of
The Circulation Foundation has been working hard
the workshops detailed below. They will help you on your way
to increase public knowledge of vascular disease and is
holding a National Awareness Week from 19th to 23rd of
Beginning a Systematic Review Protocol
March 2012. Visit www.circulationfoundation.org.uk for
The Methods Section of the Protocol The Cochrane PVD group wish you all a very peaceful Analysis Methods for Systematic Reviews Christmas and best wishes for the New Year! Advanced Topics in the Analysis and Reporting of Systematic Reviews Systematic Reviews in Medicine
Freiburg, Germany: 22nd to 24th March 2012
For more details and more courses please visit:
http://www.cochrane.org/tags/news-events/workshops
Exploring Issues of Philosophy, Principle and Conscience in Contemporary Health Care The Prostate This article was excerpted from Dr. Ronald Wheeler’s surgery, radiation, etc. ) which leave the individual with writing and reproduced with permission of the McAlvany continuing pain or other symptoms and a progressive Health Newsletter’s editor. slow slide toward prostate cancer,
IN GEEN GEVAL TOT HET BITTERE EIND Zodra de ziekte hem grote beperkingen gaat opleggen, wil Frits Hage (71) niet langer leven. Hij ziet de feiten onder ogen, gaat vaak naar het alzheimer-café en geniet zoveel mogelijk van het leven . Door Anja Krabben Als iemand bij de dag leeft, is het Frits Hage. Hij heeft de ziekte van Alzheimer, maar, zoals hij zelf zegt: ‘Ik heb er nog geen moment wa